1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Analyze analyst forecasts for the company and compare them with competitors.
251.32M
Better than TLRY's estimated revenue of 208.03M.
20.82M
Better than TLRY's estimated ebitda of 20.50M.
-2.93
Worse than TLRY's estimated eps of -2.93.
-2.18B
Worse than TLRY's estimated net income of -2.18B.
-21.29M
Worse than TLRY's estimated ebit of -6.98M.
83.22M
Worse than TLRY's estimated sg&a expense of 68.89M.
View analysts' price targets and recommendations, and compare them with competitors.
No Data
No price target data available for this metric.
Hold
Equal to TLRY's analyst recommendation of Hold.
Analyze DCF forecasts for the company and compare them with competitors.
1.14B
Revenue has increased from the previous period.
25.80%
Revenue growth rate has increased from the previous period.
-105.05M
EBITDA has increased from the previous period.
-9.23%
EBITDA margin has increased from the previous period.
-288.09M
EBIT has increased from the previous period.
-25.32%
EBIT margin has increased from the previous period.
183.03M
Depreciation has decreased from the previous period.
375.72M
Total cash has decreased from the previous period.
33.02%
Cash percentage has decreased from the previous period.
146.66M
Receivables have increased from the previous period.
12.89%
Receivables percentage has decreased from the previous period.
363.56M
Inventories have increased from the previous period.
31.95%
Inventory percentage has decreased from the previous period.
152.00M
Accounts payable has increased from the previous period.
13.36%
Payables percentage has increased from the previous period.
-42.18M
Capital expenditure has increased from the previous period.
-3.71%
CapEx percentage has increased from the previous period.
14.19%
WACC has decreased from the previous period.
14.92%
Cost of equity is unchanged from the previous period.
12.72%
Cost of debt is unchanged from the previous period.
2.19
Beta is unchanged from the previous period.
742.65M
Diluted shares outstanding is unchanged from the previous period.
558.58M
Total debt is unchanged from the previous period.
1.30B
Total equity is unchanged from the previous period.
1.86B
Total capital is unchanged from the previous period.
30.06%
Debt weighting is unchanged from the previous period.
69.94%
Equity weighting is unchanged from the previous period.
-283.41M
EBIAT has increased from the previous period.
-189.34M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-11.86B
Terminal value is unchanged from the previous period.
-9.55B
Enterprise value has decreased from the previous period.
229.28M
Net debt is unchanged from the previous period.
-9.78B
Equity value has decreased from the previous period.
-13.17
Equity value per share has decreased from the previous period.
